At the pandemic’s outset, uOttawa researcher Michael Organ was approached by Toronto Research Chemicals (TRC) to create a flow reactor that manufactures a key molecule used to prepare PCR test kits to diagnose COVID-19. Billions of tests have since been performed around the world thanks to his flow reactor technology.
At the pandemic’s outset, uOttawa researcher Michael Organ was approached by Toronto Research Chemicals (TRC) to create a flow reactor that manufactures a key molecule used to prepare PCR test kits to diagnose COVID-19. Billions of tests have since been performed around the world thanks to his flow...
Once again this year, two researchers at early stages in their careers shine bright among uOttawa’s research community. The Office of the Vice-President, Research and Innovation is pleased to present the Early Career Researcher of the Year Award to Erin Maloney, a Faculty of Social Sciences professor who holds the Canada Research Chair in Academic Achievement and Well-Being, and to Peter Tanuseput...
Once again this year, two researchers at early stages in their careers shine bright among uOttawa’s research community. The Office of the Vice-President, Research and Innovation is pleased to present the Early Career Researcher of the Year Award to Erin Maloney, a Faculty of Social Sciences professo...
The COVID-19 pandemic led to increased weekday screentime for school-aged children says a new study involving the University of Ottawa published in JAMA Pediatrics.
The COVID-19 pandemic led to increased weekday screentime for school-aged children says a new study involving the University of Ottawa published in JAMA Pediatrics.
Physicists and physical chemists from the University of Würzburg and the University of Ottawa have solved a decades-old problem of distinguishing single and multiple light excitations.
Physicists and physical chemists from the University of Würzburg and the University of Ottawa have solved a decades-old problem of distinguishing single and multiple light excitations.
Researchers have treated the first patient in an innovative clinical trial of a cell therapy that aims to prevent very premature babies from developing a chronic lung disease called bronchopulmonary dysplasia (BPD). This is the first trial of its kind in in the world.
Researchers have treated the first patient in an innovative clinical trial of a cell therapy that aims to prevent very premature babies from developing a chronic lung disease called bronchopulmonary dysplasia (BPD). This is the first trial of its kind in in the world.
Researchers have treated the first patient in an innovative clinical trial of a cell therapy that aims to prevent very premature babies from developing a chronic lung disease called bronchopulmonary dysplasia (BPD). This is the first trial of its kind in in the world.
Researchers have treated the first patient in an innovative clinical trial of a cell therapy that aims to prevent very premature babies from developing a chronic lung disease called bronchopulmonary dysplasia (BPD). This is the first trial of its kind in in the world.
With the Mois de la Francophonie well underway on campus, the University of Ottawa is continuing to strengthen collaborations with its strategic partners in France.
With the Mois de la Francophonie well underway on campus, the University of Ottawa is continuing to strengthen collaborations with its strategic partners in France.